New Results
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
View ORCID ProfileLaura Vangeel, View ORCID ProfileWinston Chiu, View ORCID ProfileSteven De Jonghe, View ORCID ProfilePiet Maes, Bram Slechten, Joren Raymenants, View ORCID ProfileEmmanuel André, View ORCID ProfilePieter Leyssen, View ORCID ProfileJohan Neyts, View ORCID ProfileDirk Jochmans
doi: https://doi.org/10.1101/2021.12.27.474275
Laura Vangeel
1KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium
Winston Chiu
1KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium
Steven De Jonghe
1KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium
Piet Maes
2KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Clinical and Epidemiological Virology, Leuven, Belgium
Bram Slechten
3University Hospitals Leuven, Department of Laboratory Medicine, Leuven, Belgium
Joren Raymenants
3University Hospitals Leuven, Department of Laboratory Medicine, Leuven, Belgium
4KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Clinical Bacteriology and Mycology, Leuven, Belgium
Emmanuel André
3University Hospitals Leuven, Department of Laboratory Medicine, Leuven, Belgium
4KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Clinical Bacteriology and Mycology, Leuven, Belgium
Pieter Leyssen
1KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium
Johan Neyts
1KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium
Dirk Jochmans
1KU Leuven, Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Virology and Chemotherapy, Leuven, Belgium
Article usage
Posted January 15, 2022.
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
Laura Vangeel, Winston Chiu, Steven De Jonghe, Piet Maes, Bram Slechten, Joren Raymenants, Emmanuel André, Pieter Leyssen, Johan Neyts, Dirk Jochmans
bioRxiv 2021.12.27.474275; doi: https://doi.org/10.1101/2021.12.27.474275
Remdesivir, Molnupiravir and Nirmatrelvir remain active against SARS-CoV-2 Omicron and other variants of concern
Laura Vangeel, Winston Chiu, Steven De Jonghe, Piet Maes, Bram Slechten, Joren Raymenants, Emmanuel André, Pieter Leyssen, Johan Neyts, Dirk Jochmans
bioRxiv 2021.12.27.474275; doi: https://doi.org/10.1101/2021.12.27.474275
Subject Area
Subject Areas
- Biochemistry (11718)
- Bioengineering (8724)
- Bioinformatics (29132)
- Biophysics (14936)
- Cancer Biology (12051)
- Cell Biology (17360)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14146)
- Epidemiology (2067)
- Evolutionary Biology (18269)
- Genetics (12223)
- Genomics (16768)
- Immunology (11844)
- Microbiology (28016)
- Molecular Biology (11560)
- Neuroscience (60822)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10401)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)